Skip to main content

Table 2 Admission and treatment of end-stage gynecologic cancer patients

From: Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution

Parameter

Total (N = 193)

Reason for last admission

 Palliative procedure or surgery

28 (14.5)

 Gastrointestinal symptoms

52 (26.9)

 Cardiovascular or pulmonary symptoms

39 (20.2)

 Infectious state

31 (16.2)

 Uncontrolled pain

11 (5.7)

 Hematologic instability

12 (6.2)

 Neurologic symptom

7 (3.6)

 Others

13 (6.7)

ICU admission in the last month

23 (11.9)

Imaging examination conducted in the last month

 No examination

56 (29.0)

 Examination

137 (71.0)

  CT

101 (73.7)

  MRI

8 (5.8)

  PET-CT

1 (0.7)

  Combined imaging (>  2)

27 (19.7)

Type of treatment administered during the last 6 mo

 Chemotherapy alone

155 (80.3)

 Chemotherapy with radiation

26 (13.5)

 Chemotherapy with surgery

12 (6.2)

  Gastrointestinal surgery

9

  Pelvic exenteration

2

  Neuro-surgery

1

Type of chemotherapy-agent administered during the last 6 mo

 IV only

177 (91.7)

 IV with PO

16 (8.3)

  1. Data are presented as n (%) unless otherwise specified
  2. ICU intensive care unit, CT computed tomography, MRI magnetic resonance imaging, PET-CT positron emission tomography-computed tomography, IV intravenous, PO per os